Please provide your email address to receive an email when new articles are posted on . The FDA approved quizartinib for use in combination with standard chemotherapy for treatment of patients with ...
NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
FMS-like tyrosine kinase 3 (FLT3) mutations, particularly internal tandem duplications and point mutations in the tyrosine kinase domain, are frequently observed in acute myeloid leukemia (AML) and ...
Cancer researchers at the University of Chicago and the University of California, San Francisco (UCSF) have discovered that mutations in certain genes can lead to the accumulation of DNA errors, ...
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer Responses occurred in 23 (30%) of 76 patients, including 10 (13%) complete remissions (CR) of any type (two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback